JORDAN HARRIS: Open Payments
NPI 1093200198 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,726 in 198 payments from 21 companies in 2025. Trend: 2023 $2,943 · 2024 $3,374 · 2025 $3,726
Food & beverage: $3,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 69 | $1,294 |
| Lundbeck LLC | 25 | $452 |
| PFIZER INC. | 26 | $329 |
| Teva Pharmaceuticals USA, Inc. | 11 | $239 |
| Merz Pharmaceuticals, LLC | 10 | $202 |
| Neurocrine BioSciences, Inc. | 10 | $196 |
| Lilly USA, LLC | 8 | $156 |
| Eisai Inc. | 7 | $137 |
| TG Therapeutics, Inc. | 5 | $101 |
| ARGENX US, INC. | 4 | $98 |
Products named: QULIPTA, VYEPTI, UBRELVY, NURTEC ODT, BOTOX, INBRIJA, INGREZZA, AJOVY.
Industry payments across OK — which companies pay providers there.
